- Home
- EMCG vs KZR Comparison
EMCG vs KZR Comparison
Compare EMCG & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMCG
- KZR
- Stock Information
- Founded
- EMCG 2021
- KZR 2015
- Country
- EMCG United States
- KZR United States
- Employees
- EMCG N/A
- KZR N/A
- Industry
- EMCG
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- EMCG
- KZR Health Care
- Exchange
- EMCG NYSE
- KZR Nasdaq
- Market Cap
- EMCG 52.4M
- KZR 46.5M
- IPO Year
- EMCG 2022
- KZR 2018
- Fundamental
- Price
- EMCG $11.70
- KZR $6.19
- Analyst Decision
- EMCG
- KZR Hold
- Analyst Count
- EMCG 0
- KZR 2
- Target Price
- EMCG N/A
- KZR $9.00
- AVG Volume (30 Days)
- EMCG 2.6K
- KZR 48.3K
- Earning Date
- EMCG 01-01-0001
- KZR 03-13-2025
- Dividend Yield
- EMCG N/A
- KZR N/A
- EPS Growth
- EMCG N/A
- KZR N/A
- EPS
- EMCG 0.23
- KZR N/A
- Revenue
- EMCG N/A
- KZR N/A
- Revenue This Year
- EMCG N/A
- KZR N/A
- Revenue Next Year
- EMCG N/A
- KZR N/A
- P/E Ratio
- EMCG $50.08
- KZR N/A
- Revenue Growth
- EMCG N/A
- KZR N/A
- 52 Week Low
- EMCG $11.70
- KZR $5.20
- 52 Week High
- EMCG $13.39
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- EMCG 65.37
- KZR 38.28
- Support Level
- EMCG $11.63
- KZR $6.15
- Resistance Level
- EMCG $11.74
- KZR $6.50
- Average True Range (ATR)
- EMCG 0.00
- KZR 0.29
- MACD
- EMCG 0.00
- KZR -0.02
- Stochastic Oscillator
- EMCG 55.56
- KZR 5.13
About EMCG EMBRACE CHANGE ACQUISITION CORP
Embrace Change Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.